These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38320121)

  • 1. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels.
    de Vries PS; Reventun P; Brown MR; Heath AS; Huffman JE; Le NQ; Bebo A; Brody JA; Temprano-Sagrera G; Raffield LM; Ozel AB; Thibord F; Jain D; Lewis JP; Rodriguez BAT; Pankratz N; Taylor KD; Polasek O; Chen MH; Yanek LR; Carrasquilla GD; Marioni RE; Kleber ME; Trégouët DA; Yao J; Li-Gao R; Joshi PK; Trompet S; Martinez-Perez A; Ghanbari M; Howard TE; Reiner AP; Arvanitis M; Ryan KA; Bartz TM; Rudan I; Faraday N; Linneberg A; Ekunwe L; Davies G; Delgado GE; Suchon P; Guo X; Rosendaal FR; Klaric L; Noordam R; van Rooij F; Curran JE; Wheeler MM; Osburn WO; O'Connell JR; Boerwinkle E; Beswick A; Psaty BM; Kolcic I; Souto JC; Becker LC; Hansen T; Doyle MF; Harris SE; Moissl AP; Deleuze JF; Rich SS; van Hylckama Vlieg A; Campbell H; Stott DJ; Soria JM; de Maat MPM; Almasy L; Brody LC; Auer PL; Mitchell BD; Ben-Shlomo Y; Fornage M; Hayward C; Mathias RA; Kilpeläinen TO; Lange LA; Cox SR; März W; Morange PE; Rotter JI; Mook-Kanamori DO; Wilson JF; van der Harst P; Jukema JW; Ikram MA; Blangero J; Kooperberg C; Desch KC; Johnson AD; Sabater-Lleal M; Lowenstein CJ; Smith NL; Morrison AC
    Blood; 2024 May; 143(18):1845-1855. PubMed ID: 38320121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels.
    Sabater-Lleal M; Huffman JE; de Vries PS; Marten J; Mastrangelo MA; Song C; Pankratz N; Ward-Caviness CK; Yanek LR; Trompet S; Delgado GE; Guo X; Bartz TM; Martinez-Perez A; Germain M; de Haan HG; Ozel AB; Polasek O; Smith AV; Eicher JD; Reiner AP; Tang W; Davies NM; Stott DJ; Rotter JI; Tofler GH; Boerwinkle E; de Maat MPM; Kleber ME; Welsh P; Brody JA; Chen MH; Vaidya D; Soria JM; Suchon P; van Hylckama Vlieg A; Desch KC; Kolcic I; Joshi PK; Launer LJ; Harris TB; Campbell H; Rudan I; Becker DM; Li JZ; Rivadeneira F; Uitterlinden AG; Hofman A; Franco OH; Cushman M; Psaty BM; Morange PE; McKnight B; Chong MR; Fernandez-Cadenas I; Rosand J; Lindgren A; ; Gudnason V; Wilson JF; Hayward C; Ginsburg D; Fornage M; Rosendaal FR; Souto JC; Becker LC; Jenny NS; März W; Jukema JW; Dehghan A; Trégouët DA; Morrison AC; Johnson AD; O'Donnell CJ; Strachan DP; Lowenstein CJ; Smith NL
    Circulation; 2019 Jan; 139(5):620-635. PubMed ID: 30586737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endothelial lectin clearance receptor CLEC4M binds and internalizes factor VIII in a VWF-dependent and independent manner.
    Swystun LL; Notley C; Georgescu I; Lai JD; Nesbitt K; James PD; Lillicrap D
    J Thromb Haemost; 2019 Apr; 17(4):681-694. PubMed ID: 30740857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF-FVIII clearance in thrombosis and hemostasis.
    Swystun LL; Michels A; Lillicrap D
    J Thromb Haemost; 2023 Aug; 21(8):2007-2019. PubMed ID: 37085036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels.
    Antoni G; Oudot-Mellakh T; Dimitromanolakis A; Germain M; Cohen W; Wells P; Lathrop M; Gagnon F; Morange PE; Tregouet DA
    BMC Med Genet; 2011 Aug; 12():102. PubMed ID: 21810271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.
    Swystun LL; Georgescu I; Mewburn J; Deforest M; Nesbitt K; Hebert K; Dwyer C; Brown C; Notley C; Lillicrap D
    J Thromb Haemost; 2017 Aug; 15(8):1607-1619. PubMed ID: 28581694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African Americans.
    Tang W; Cushman M; Green D; Rich SS; Lange LA; Yang Q; Tracy RP; Tofler GH; Basu S; Wilson JG; Keating BJ; Weng LC; Taylor HA; Jacobs DR; Delaney JA; Palmer CD; Young T; Pankow JS; O'Donnell CJ; Smith NL; Reiner AP; Folsom AR
    Am J Hematol; 2015 Jun; 90(6):534-40. PubMed ID: 25779970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium.
    Smith NL; Chen MH; Dehghan A; Strachan DP; Basu S; Soranzo N; Hayward C; Rudan I; Sabater-Lleal M; Bis JC; de Maat MP; Rumley A; Kong X; Yang Q; Williams FM; Vitart V; Campbell H; Mälarstig A; Wiggins KL; Van Duijn CM; McArdle WL; Pankow JS; Johnson AD; Silveira A; McKnight B; Uitterlinden AG; ; Aleksic N; Meigs JB; Peters A; Koenig W; Cushman M; Kathiresan S; Rotter JI; Bovill EG; Hofman A; Boerwinkle E; Tofler GH; Peden JF; Psaty BM; Leebeek F; Folsom AR; Larson MG; Spector TD; Wright AF; Wilson JF; Hamsten A; Lumley T; Witteman JC; Tang W; O'Donnell CJ
    Circulation; 2010 Mar; 121(12):1382-92. PubMed ID: 20231535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity and reciprocity of FVIII and VWF expression, and the response to shear stress in cultured human endothelial cells.
    Hough C; Notley C; Mo A; Videl B; Lillicrap D
    J Thromb Haemost; 2022 Nov; 20(11):2507-2518. PubMed ID: 35950488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity.
    Swystun LL; Lai JD; Notley C; Georgescu I; Paine AS; Mewburn J; Nesbitt K; Schledzewski K; Géraud C; Kzhyshkowska J; Goerdt S; Hopman W; Montgomery RR; James PD; Lillicrap D
    J Clin Invest; 2018 Aug; 128(9):4057-4073. PubMed ID: 30124466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII pharmacokinetics associates with genetic modifiers of VWF and FVIII clearance in an adult hemophilia A population.
    Ogiwara K; Swystun LL; Paine AS; Kepa S; Choi SJ; Rejtö J; Hopman W; Pabinger I; Lillicrap D
    J Thromb Haemost; 2021 Mar; 19(3):654-663. PubMed ID: 33219619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci.
    De Visser MC; Sandkuijl LA; Lensen RP; Vos HL; Rosendaal FR; Bertina RM
    J Thromb Haemost; 2003 Aug; 1(8):1771-6. PubMed ID: 12911592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.
    Sanders YV; van der Bom JG; Isaacs A; Cnossen MH; de Maat MP; Laros-van Gorkom BA; Fijnvandraat K; Meijer K; van Duijn CM; Mauser-Bunschoten EP; Eikenboom J; Leebeek FW;
    J Thromb Haemost; 2015 Jun; 13(6):956-66. PubMed ID: 25832887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.
    Boylan B; Rice AS; De Staercke C; Eyster ME; Yaish HM; Knoll CM; Bean CJ; Miller CH;
    J Thromb Haemost; 2015 Jun; 13(6):1036-42. PubMed ID: 25780857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity von Willebrand factor binding does not affect the anatomical or hepatocellular distribution of factor VIII in rats.
    Øie CI; Roepstorff K; Behrens C; Bøggild Kristensen J; Karpf DM; Bolt G; Gudme CN; Kjalke M; Smedsrød B; Appa RS
    J Thromb Haemost; 2016 Sep; 14(9):1803-13. PubMed ID: 27378673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients.
    Swystun LL; Ogiwara K; Rawley O; Brown C; Georgescu I; Hopman W; Labarque V; Male C; Thom K; Blanchette VS; Carcao MD; Lillicrap D
    Blood; 2019 Sep; 134(11):880-891. PubMed ID: 31350267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of a unique von Willebrand disease variant. A novel mutation affecting von Willebrand factor/factor VIII interaction.
    Cacheris PM; Nichols WC; Ginsburg D
    J Biol Chem; 1991 Jul; 266(21):13499-502. PubMed ID: 1906877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mendelian Randomization Analysis of Hemostatic Factors and Their Contribution to Peripheral Artery Disease-Brief Report.
    Small AM; Huffman JE; Klarin D; Sabater-Lleal M; Lynch JA; Assimes TL; Sun YV; Miller D; Freiberg MS; Morrison AC; Rader DJ; Wilson PWF; Cho K; Tsao PS; Chang KM; Smith NL; O'Donnell CJ; de Vries PS; Damrauer SM;
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):380-386. PubMed ID: 32847391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
    Miller CH; Kelley L; Green D
    Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cell surface expression and binding of factor VIII/von Willebrand factor.
    Jones TR; Kao KJ; Pizzo SV; Bigner DD
    Am J Pathol; 1981 May; 103(2):304-8. PubMed ID: 6786103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.